RxDoctor Payments Data

Megann Dees, PA

Physician Assistant · Vicksburg, MSNPI 1427759513

Payments from drug & device makers

$775in general payments, 2019–2025

Across 35 payments — averaging $22.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$163
  • AstraZeneca$146
  • Astellas Pharma US Inc$69
  • Novartis$69
  • Merck$57
  • AbbVie$53
  • plus $217 from 10 others

What the payments were for

  • Food & beverage$775100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$775 in reported general payments places this provider in the 55th percentile of 278 physician assistant providers in Mississippi.

See all physician assistant providers in Mississippi

Medicare billing

Part B allowed, 2024
$64,781
Medicare patients
137
Services billed
2,114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter169$135,551
TrulicityDulaglutide119$120,147
OzempicSemaglutide86$80,656
JanuviaSitagliptin Phosphate37$42,854
RybelsusSemaglutide29$39,085
XareltoRivaroxaban30$33,858
MyrbetriqMirabegron35$32,714
FarxigaDapagliflozin Propanediol26$29,322
LinzessLinaclotide31$23,668
TradjentaLinagliptin16$19,128
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$14,996
EliquisApixaban17$14,763
BrilintaTicagrelor19$13,339
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$8,302
Albuterol Sulfate HfaAlbuterol Sulfate129$3,703

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$40$135,551169 claims
Novo NordiskOzempic, Rybelsus$14$119,742115 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta$146$57,65663 claims
MerckJanuvia$57$42,85437 claims
Astellas Pharma US IncMyrbetriq$69$32,71435 claims
AbbVieLinzess, Synthroid$53$24,70947 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 278 physician assistant providers in Mississippi.

Other physician assistant in Vicksburg

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →